Success Metrics

Clinical Success Rate
92.0%

Based on 23 completed trials

Completion Rate
92%(23/25)
Active Trials
4(13%)
Results Posted
13%(3 trials)
Terminated
2(6%)

Phase Distribution

Ph phase_4
3
9%
Ph phase_2
4
13%
Ph not_applicable
21
66%

Phase Distribution

0

Early Stage

4

Mid Stage

3

Late Stage

Phase Distribution28 total trials
Phase 2Efficacy & side effects
4(14.3%)
Phase 4Post-market surveillance
3(10.7%)
N/ANon-phased studies
21(75.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

92.0%

23 of 25 finished

Non-Completion Rate

8.0%

2 ended early

Currently Active

4

trials recruiting

Total Trials

32

all time

Status Distribution
Active(5)
Completed(23)
Terminated(2)
Other(2)

Detailed Status

Completed23
Recruiting3
Terminated2
unknown2
Active, not recruiting1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
32
Active
4
Success Rate
92.0%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (14.3%)
Phase 43 (10.7%)
N/A21 (75.0%)

Trials by Status

terminated26%
unknown26%
completed2372%
active_not_recruiting13%
recruiting39%
not_yet_recruiting13%

Recent Activity

Clinical Trials (32)

Showing 20 of 32 trialsScroll for more
NCT04157101Not Applicable

Health Coaching for Chronic Multisymptom Illness

Completed
NCT05777200

Sociodemographic and Clinical Characteristics of Patients Admitted to the Addiction Management Unit

Completed
NCT06072898Phase 2

A Randomized Neuroimaging Trial of Psilocybin in Depression

Recruiting
NCT05142605Not Applicable

Evaluation of Grief Therapy Approaches for Bereaved Parents

Recruiting
NCT07449104Not Applicable

The Effectiveness of Dialectical Behavioral Group Psychotherapy Compared to Supportive Individual Psychotherapy In Patients With Borderline Personality Disorder: A Study on Therapeutic Alliance, Depression, Cognitive Function, Impulsivity, Suicide Risk, BDNF Levels, NFkB Levels, SOD Levels

Completed
NCT07213596Not Applicable

Virtual Reality Treatment for Trauma Related to COVID-19 Infection

Not Yet Recruiting
NCT05574127Phase 2

A Study of Brief Behavioral Activation for the Treatment of Depression in Older Adult Cancer Survivors

Active Not Recruiting
NCT04490265Not Applicable

Suicide Prevention for Patients With Chronic Pain

Completed
NCT04902339Not Applicable

Near-infrared Spectroscopy-based Neurofeedback as Adjunct to Mindfulness-Oriented Recovery Enhancement in Persons With Chronic Pain

Completed
NCT00667212Not Applicable

Psychotherapy for Intermittent Explosive Disorder

Completed
NCT02552836Not Applicable

Efficacy of Psychotherapy for Depressed Parkinson's Disease Patients

Completed
NCT02698696Not Applicable

Validation of a Cognitive Remediation Program for Bipolar Disorders

Recruiting
NCT00533117Phase 4

Treating Suicidal Behavior and Self-Mutilation in People With Borderline Personality Disorder

Completed
NCT03552120Not Applicable

Serving Women Using Opioids During Pregnancy

Terminated
NCT05648123Not Applicable

Effectiveness of Supportive Psychotherapy Through Internet-Based Teleconsultation on Psychological and Somatic Symptoms, Neutrophil-Lymphocyte Ratio, and Heart Rate Variability in Post Covid-19 Syndrome Patients

Completed
NCT05025670

Tracking Response in Advance of Investigational Trials, Borderline Study

Completed
NCT02630069Phase 2

CDP-choline Treatment in ATS Users

Unknown
NCT04868734Not Applicable

Superficial Supportive Psychotherapy Model and Its Effect on Acute Coronary Syndrome Psycho-Neuro-Endocrine Studies

Completed
NCT01453439Not Applicable

Cognitive-Behavioral Therapy and Supportive Psychotherapy for Body Dysmorphic Disorder

Completed
NCT01465919Phase 4

Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C

Terminated

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
32